Biological Drivers of IMiD-Induced Peripheral Neuropathy in Multiple Myeloma
{{output}}
The introduction of immunomodulatory drugs (IMiDs), such as thalidomide, lenalidomide and pomalidomide, have led to significant improvements in multiple myeloma (MM) treatment. Many patients now live 10 years or longer with their disease, making treatment-rela... ...